professional documents
home
Profile
docsters
request
Blogs
Upload

search results


www fda gov cdrh comp guidance pdf - Complete list of MDUFMA related Federal Register Announcements

GovernmentDocs 5/4/2008 | 0 (0) | 12 | 0 | 0 | English

Contains Nonbinding RecommendationsGuidance for Industry, FDA Staff, and FDA-Accredited Third PartiesRequests for Inspection by an Accredited Person under the Inspection by Accredited Persons  ... more>>

The Inspection is Over What Happens Next Possible FDA Enforcement Actions PDF KB Presentations

FDADocs 5/9/2008 | 0 (0) | 10 | 0 | 0 | English

The Inspection is Over ??? What Happens Next? Possible FDA Enforcement ActionsPatricia HolobaughFDA Center for Biologics Evaluation and Research Division of Inspections and SurveillanceThe  ... more>>

FDA CFSAN OPA Agency Response Letter to Cargill Incorporated on vegetable oil phytosterol esters

FDADocs 5/9/2008 | 0 (0) | 21 | 0 | 0 | English

FDA/CFSAN/OPA : Agency Response Letter : GRAS Notice No . GRN 000048Page 1 of 3_U. S. Food and Drug Administration Center for Food Safety & Applied NutritionOffice of Premarket  ... more>>

Exposure Response Application to Antimicrobial Drug Development IDSA PhRma FDA Working Group Meeting

FDADocs 5/12/2008 | 0 (0) | 21 | 0 | 0 | English

Exposure-Response: Application to Antimicrobial Drug DevelopmentIDSA/PhRMA/FDA Workshop November... Pharmacology and Biopharmaceutics IDSA/PhRMA/FDA Workshop 11/19/02Guidances: Exposure-Response (E-R  ... more>>

Jenny J Zheng ppt FDA IDSA ISAP Working Group Meeting Presentations and Transcripts

FDADocs 5/9/2008 | 0 (0) | 20 | 0 | 0 | English

Improvement in Dose Selection: FDA PerspectiveIDSA/ISAP/FDA Workshop April 16, 2004Jenny J Zheng, Ph.D. Pharmacometrician DPEIII/OCPB/CDER/FDAOffice of Clinical Pharmacology and  ... more>>

Draft Guidance for Industry and FDA Staff: In Vitro Diagnostic (IVD) Device Studies Frequently Asked Questions

GovernmentDocs 5/4/2008 | 0 (0) | 43 | 0 | 0 | English

Guidance for Sponsors, Institutional Review Boards, Clinical Investigators and FDA Staff Guidance... document contact Sally Hojvat, Ph.D., at 240-276-0496 or by email at sally.hojvat@fda.hhs.gov.U.S  ... more>>

Independent Evaluation of FDA s First Cycle Review Performance Retrospective Analysis Final Report

GovernmentDocs 5/4/2008 | 0 (0) | 19 | 0 | 0 | English

Prescription Drug User Fee Act III ??? Initiatives & EvaluationsContract No. 223-04-8100 Task No. T1Independent Evaluation of FDA???s First Cycle Review Performance ??? Retrospective Analysis  ... more>>

Questions and Answers About FDA s Enforcement Action Against Timed Release Drug Products Containing Guaifenesin

FDADocs 5/5/2008 | 0 (0) | 8 | 0 | 0 | English

1Questions and Answers about FDA???s Enforcement Action Against Unapproved Timed-Release Guaifenesin ProductsWhat action is FDA taking concerning timed-release drug products containing  ... more>>

Draft Guidance for Industry Clinical Laboratories and FDA Staff: In Vitro Diagnostic Multivariate Index Assays

GovernmentDocs 5/5/2008 | 0 (0) | 27 | 0 | 0 | English

Draft Guidance for Industry and FDA Staff Modifications to Devices Subject to Premarket Approval (PMA) ??? The PMA Supplement Decision-Making ProcessDRAFT GUIDANCEThis guidance document is being  ... more>>


   
  results / page   15/25/50 Page: 33 of 33 << prev 1...30313233 next >>